Shane Kovacs - Feb 28, 2025 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CH. OPERATING & FINANCIAL OFF.
Signature
/s/ Shane Kovacs
Stock symbol
OLMA
Transactions as of
Feb 28, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 04:16 PM
Previous filing
Dec 11, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Award $0 +320K $0.00 320K Feb 28, 2025 Common Stock 320K $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.